Related Experiment Video
Updated: May 9, 2026

10:53
Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
Using iPSC models to examine neuron-glia interactions in neurodegenerative diseases
Dianne M Lopez1,2, Lois K Keavey1,2, Kathryn R Bowles1,2
1UK Dementia Research Institute at the University of Edinburgh, Edinburgh, EH16 4SB, Scotland, U.K.
Bioscience Reports
|May 8, 2026
Summary
Glial cells are crucial in neurodegenerative diseases, and studying neuron-glia interactions using induced pluripotent stem cell (iPSC) models offers new therapeutic insights.
Area of Science:
- Neuroscience
- Cell Biology
- Stem Cell Research
Background:
- Neurodegenerative diseases lack effective treatments and are a growing global health concern.
- These disorders involve progressive neuronal and synaptic loss, impacting cognition and motor function.
- Glial cells, not just neurons, are increasingly recognized for their critical roles in brain health.
Purpose of the Study:
- To explore the role of glial cell dysregulation in neurodegenerative disease onset and progression.
- To investigate mechanisms of neuron-glia interaction disruptions in disease.
- To highlight the utility of induced pluripotent stem cell (iPSC)-based models for studying these interactions.
Main Methods:
- Utilizing human induced pluripotent stem cell (iPSC) models.
- Modeling neuron-glia interactions in vitro.
- Analyzing mechanisms of glial dysregulation in neurodegeneration.
Main Results:
- Glial dysregulation contributes to neurodegeneration via aberrant protein clearance, inflammation, and metabolic dysfunction.
- Disrupted neuron-glia communication exacerbates neuronal dysfunction.
- iPSC models reveal specific pathways linking glial dysfunction to disease pathology.
Conclusions:
- Understanding neuron-glia interactions is essential for developing effective neurodegenerative disease therapies.
- Human iPSC models provide valuable insights into disease mechanisms.
- Targeting glial cell function represents a promising therapeutic strategy.
